BioLingus (Cayman) Limited (SUBL)

BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.

IPO Price

$20.00

Shares Offered

360,000

Deal Size

$7.20M

SUBL Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Operating Activities

Year Ending	TTM	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Net Income	-0.58	-1.42	-2.03
Depreciation & Amortization	0.11	0.16	0.22
Other Operating Activities	0.15	0.71	0.16
Operating Cash Flow	-0.33	-0.55	-1.65
Operating Cash Flow Growth	-	-	-

Year Ending	TTM	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Debt Issued / Paid	-	0.62	1.66
Financing Cash Flow	0.47	0.62	1.66

Year Ending	TTM	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Net Cash Flow	0.14	0.07	0.01

Year Ending	TTM	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Free Cash Flow	-0.33	-0.55	-1.65
Free Cash Flow Growth	-	-	-